HTLV-1 uveitis (HU)

Leukemia

Volumn 11, Issue SUPPL. 3, 1997, Pages 582-584

  Watanabe, Toshiki ^a   Mochizuki, Manabu ^b   Yamaguchi, Kazunari ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATORY DISEASE; LONG TERMINAL REPEAT; PATHOGENESIS; PRIORITY JOURNAL; TRANSACTIVATION; UVEITIS;

EID: 0030800327     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Poiesz BJ et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA, 1980; 77: 7415-7419.
2. Yoshida M et al. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA, 1984; 81: 2534-2537.
3. Gessain A et al. Antibodies to human T lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet, 1985; ii: 407-410.
4. Osame M et al. HTLV-1 associated myelopathy, a new clinical entity. Lancet, 1986; 1: 1031-1032.
5. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet, 1994; 343: 213-216.
6. Mochizuki M et al. HTLV-1 and uveitis. Lancet, 1992; 339: 1110.
7. Mochizuki M et al. HTLV-1 Uveitis: a distinct clinical entity caused by HTLV-1. Jpn J Cancer Res, 1992; 83: 236-239.